In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer’s Disease: A <sup>18</sup>F-Florzolotau Study

In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer’s Disease: A <sup>18</sup>F-Florzolotau Study

Purpose: <sup>18</sup>F-Florzolotau is a novel second-generation tau radiotracer that shows higher binding affinity and selectivity and no off-target binding. The proportion loss of functional connectivity strength (PLFCS) is a new indicator for representing brain functional connectivity...

Full description

Bibliographic Details
Main Authors:	Zizhao Ju, Zhuoyuan Li, Jiaying Lu, Fangyang Jiao, Huamei Lin, Weiqi Bao, Ming Li, Ping Wu, Yihui Guan, Qianhua Zhao, Huiwei Zhang, Jiehui Jiang, Chuantao Zuo
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Brain Sciences
Subjects:	Florzolotau PET functional connectivity mild cognitive impairment Alzheimer’s disease
Online Access:	https://www.mdpi.com/2076-3425/12/10/1355

Similar Items

Human biodistribution and radiation dosimetry for the tau tracer [18F]Florzolotau in healthy subjects
by: Kun-Ju Lin, et al.
Published: (2024-04-01)

Visual reading for [18F]Florzolotau ([18F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
by: Huan-Chun Lin, et al.
Published: (2023-05-01)

Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [18F]Florzolotau PET imaging and subtype/stage inference algorithmResearch in context
by: Jimin Hong, et al.
Published: (2023-11-01)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
by: Fangyang Jiao, et al.
Published: (2023-02-01)

Brain Network and Abnormal Hemispheric Asymmetry Analyses to Explore the Marginal Differences in Glucose Metabolic Distributions Among Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy Body Dementia
by: Danyan Chen, et al.
Published: (2019-04-01)

Improved interpretation of 18F-florzolotau PET in progressive supranuclear palsy using a normalization-free deep-learning classifier
by: Jiaying Lu, et al.
Published: (2023-08-01)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
by: Hucheng Zhou, et al.
Published: (2019-01-01)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
by: Anna Rubinski, et al.
Published: (2020-10-01)

Multicenter <sup>18</sup>F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
by: Michael Rullmann, et al.
Published: (2022-03-01)

Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [18F]-APN-1607 Study
by: Huiwei Zhang, et al.
Published: (2021-06-01)

Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints
by: Jiaying Lu, et al.
Published: (2023-06-01)

Role of Combined <sup>68</sup>Ga DOTA-Peptides and <sup>18</sup>F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms
by: Chalermrat Kaewput, et al.
Published: (2022-01-01)

Design, Synthesis, Computational, and Preclinical Evaluation of <sup>nat</sup>Ti/<sup>45</sup>Ti-Labeled Urea-Based Glutamate PSMA Ligand
by: Kristina Søborg Pedersen, et al.
Published: (2020-03-01)

Longitudinal Assessment of Tau-Associated Pathology by <sup>18</sup>F-THK5351 PET Imaging: A Histological, Biochemical, and Behavioral Study
by: Ines Moreno-Gonzalez, et al.
Published: (2021-10-01)

Brain Functional and Structural Signatures in Parkinson’s Disease
by: Chunhua Liu, et al.
Published: (2020-05-01)

The Value of <sup>68</sup>Ga-PSMA PET/CT Following Equivocal <sup>18</sup>F-NaF PET/CT in Prostate Cancer Patients
by: Claus Madsen, et al.
Published: (2020-05-01)

Recent Advances in <sup>64</sup>Cu/<sup>67</sup>Cu-Based Radiopharmaceuticals
by: Olga O. Krasnovskaya, et al.
Published: (2023-05-01)

Current Status of <sup>68</sup>Ga-Pentixafor in Solid Tumours
by: Bawinile Hadebe, et al.
Published: (2022-09-01)

Can Radiomics Provide Additional Information in [<sup>18</sup>F]FET-Negative Gliomas?
by: Katharina von Rohr, et al.
Published: (2022-10-01)

<sup>68</sup>Ga-DOTATATE and <sup>68</sup>Ga-Pentixafor PET/CT in a Patient with Castleman Disease of the Retroperitoneum
by: Rui Zuo, et al.
Published: (2024-02-01)

Diagnostic performance of artificial intelligence-assisted PET imaging for Parkinson’s disease: a systematic review and meta-analysis
by: Jing Wang, et al.
Published: (2024-01-01)

The Use of <sup>18</sup>F-FET-PET-MRI in Neuro-Oncology: The Best of Both Worlds—A Narrative Review
by: Tineke van de Weijer, et al.
Published: (2022-05-01)

Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer
by: Tine N. Christensen, et al.
Published: (2021-02-01)

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
by: Weiqi Bao, et al.
Published: (2021-05-01)

Metastatic Pulmonary Calcification Detected on <sup>18</sup>F-FDG PET/CT and <sup>99m</sup>Tc-MDP Bone Scan
by: Miju Cheon, et al.
Published: (2021-09-01)

[<sup>18</sup>F] Clofarabine for PET Imaging of Hepatocellular Carcinoma
by: Olga Sergeeva, et al.
Published: (2019-11-01)

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
by: Tessa Timmers, et al.
Published: (2019-07-01)

<sup>11</sup>C-Choline PET/CT vs. <sup>99m</sup>Tc-MIBI/<sup>123</sup>Iodide Subtraction SPECT/CT for Preoperative Detection of Abnormal Parathyroid Glands in Primary Hyperparathyroidism: A Prospective, Single-Centre Clinical Trial in 60 Patients
by: Afefah Ismail, et al.
Published: (2020-11-01)

Diagnostic Value of <sup>18</sup>F-FDG-PET/CT in Patients with FUO
by: Stamata Georga, et al.
Published: (2020-07-01)

Evaluation of a <sup>68</sup>Ga-Labeled DOTA-Tetrazine as a PET Alternative to <sup>111</sup>In-SPECT Pretargeted Imaging
by: Patricia E. Edem, et al.
Published: (2020-01-01)

The Dependence of Renal <sup>68</sup>Ga[Ga]-DOTATOC Uptake on Kidney Function and Its Relevance for Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu[Lu]-DOTATOC
by: Falk Gühne, et al.
Published: (2021-07-01)

Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on <sup>18</sup>F-FDG PET/CT and Automated Classifiers
by: Susanna Nuvoli, et al.
Published: (2022-10-01)

Head-to-Head Comparison of [<sup>18</sup>F]PSMA-1007 and [<sup>18</sup>F]FDG PET/CT in Patients with Triple-Negative Breast Cancer
by: Natalia Andryszak, et al.
Published: (2024-02-01)

Prostate Cancer Biochemical Recurrence Resulted Negative on [<sup>68</sup>Ga]Ga-PSMA-11 but Positive on [<sup>18</sup>F]Fluoromethylcholine PET/CT
by: Riccardo Laudicella, et al.
Published: (2022-09-01)

Fully Automated, High-Dose Radiosynthesis of [<sup>18</sup>F]PARPi
by: Anna Pacelli, et al.
Published: (2022-07-01)

A Case Report of Early-Onset Alzheimer’s Disease Using <sup>18</sup>F-FDG PET and <sup>18</sup>F-FBB PET
by: Jang Yoo, et al.
Published: (2023-05-01)

The Role of [<sup>68</sup>Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review
by: Domenico Albano, et al.
Published: (2022-08-01)

A Case of Chronic Neutrophilic Leukemia Incidentally Detected by <sup>18</sup>F-FDG PET/CT
by: Miju Cheon, et al.
Published: (2021-04-01)

Diagnostic Accuracy of PET with <sup>18</sup>F-Fluciclovine ([<sup>18</sup>F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis
by: Angelo Castello, et al.
Published: (2023-12-01)

<sup>18</sup>F-FDG and <sup>18</sup>F-NaF PET/CT Global Assessment of Large Joint Inflammation and Bone Turnover in Rheumatoid Arthritis
by: Natasha Reddy, et al.
Published: (2023-06-01)